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Conjugated linoleic acid influences the
metabolism of tocopherol in lactating rats
but has little effect on tissue tocopherol
concentrations in pups
Johanna O. Zeitz*, Erika Most and Klaus Eder
Abstract
Background: Conjugated linoleic acid (CLA) is known to affect the lipid metabolism in growing and lactating animals.
However, potential effects on the metabolism of fat-soluble vitamins in lactating animals and co-occurring effects on
their offspring are unknown. We aimed to investigate the effects of dietary CLA on concentrations of tocopherol in
various tissues of lactating rats and their offspring and expression of genes involved in tocopherol metabolism.
Methods: Twenty-eight Wistar Han rats were allocated to 2 groups and fed either a control diet (control group) or a
diet containing 0.9 % of cis-9, trans-11 and trans-10, cis-12 (1:1) CLA (CLA group) during pregnancy and lactation. Feed
intake of dams and body weight of dams and their pups were recorded weekly. Tocopherol concentrations in various
body tissues were determined at day 14 of lactation in dams and 1, 7 and 14 days after birth in pups. Expression of
selected genes involved in metabolism of tocopherol was determined in dams and pups. The data were statistically
analysed by analysis of variance.
Results: Feed intake and body weight development of nursing rats and their pups was similar in both groups. In livers of
CLA-fed dams, tocopherol concentrations decreased by 24 % but expression of TTPA and CYP3A1, involved in tocopherol
transport and metabolism, were not influenced. In the dams’ adipose tissue, gene expression of receptors involved in
tissue tocopherol uptake, LDLR and SCARB1, but not of LPL, increased by 30 to 50 % and tocopherol concentrations
increased by 47 % in CLA-fed compared to control dams. Expression of LPL, LDLR and SCARB1 in mammary gland was
not influenced by CLA-feeding. Tocopherol concentrations in the pup’s livers and lungs were similar in both groups, but
at 14 days of age, adipose tissue tocopherol concentrations, and LDLR and SCARB1 expression, were higher in the
CLA-exposed pups.
Conclusions: We show that dietary CLA affects tissue concentrations of tocopherol in lactating rats and tocopherol
metabolism in rats and pups, but hardly influences tissue tocopherol concentrations in their offspring. This indicates that
supplementation of CLA in pregnant and lactating animals is uncritical considering the tocopherol status of new-borns.
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Background
Dietary CLA supplements, which usually consist of a mix-
ture of the cis-9, trans-11 CLA and the trans-10, cis-12
CLA isomer, are known to influence the lipid metabolism
during lactation and growth in different species like rats
[1, 2], pigs [3] and ruminants [4, 5]. The CLA influence
the lipid metabolism by down regulating gene expression
of proteins involved in lipid synthesis and fatty acid
(FA) transport in many tissue like muscle, adipose
tissue, liver [1, 3] and mammary gland [4, 6]. Conse-
quently, the FA composition of tissues and milk is al-
tered by CLA [1, 4, 5]. Similarly, CLA might influence
the metabolism of tocopherols, which is linked to the
lipid metabolism concerning absorption and intermedi-
ary metabolism [7]. For example, tocopherols are emul-
sified by bile acids in the intestine and transported in
chylomicrons and lipoproteins together with other
lipids [7]. Likewise, the lipoprotein lipase (LPL) is not
only crucial for uptake of triglycerides (TG) and FA
from chylomicrons and very low density lipoproteins
(VLDL) into extra-hepatic tissues [8], but it is also im-
portant for uptake of tocopherols [7]. Some first studies
in growing animals indicate that feeding CLA in fact influ-
ences tissue tocopherol concentrations. For example, in
the liver of mice and rats, levels of α-tocopherol increased
when CLA was supplemented to the diet [9, 10]. The mo-
lecular mechanism underlying these observations are
largely unknown but may be related to increased levels of
the α-tocopherol transfer protein (TTPA) which is respon-
sible for retaining α-tocopherol in the body [9]. Increased
concentrations of α-tocopherol in plasma and adipose tis-
sue due to CLA feeding have been found as well [9, 10].
Tocopherol has not only important functions as an anti-
oxidant but also e.g., in cell signalling and inflammation
[7]. When changes in tocopherol status due to CLA feed-
ing occur, this may affect not only the animal fed CLA,
but, in case of pregnant and lactating animals, also growth
and development of their offspring. However, studies in-
vestigating the tocopherol metabolism in response to CLA
feeding in lactating animals and potential effects on their
offspring are missing so far. We hypothesized that diet-
ary CLA influences the tocopherol status of lactating
rats and their offspring. Therefore, we determined toc-
opherol concentrations in various tissues of dams and
their pups. Furthermore, we aimed to reveal the mo-
lecular mechanisms underlying the observed changes in
tissue tocopherol status by investigating gene expres-
sion of selected enzymes and cell membrane receptors
involved in the metabolism of tocopherol.
Methods
Animal experiment
Twenty-eight female Wistar Han rats were obtained
from Harlan Laboratories (AN Venray, The Netherlands)
at their 2nd day of pregnancy. The rats were randomly
assigned to 2 groups of 14 rats each, with an initial body
weight of 220 ± 16.2 g (mean ± SD; Control group) and
218 ± 18.5 g (CLA group) (P = 0.75). The pregnant rats
were housed in groups of 2 animals each in Macrolon
cages (type 4) enriched with cellulose papers and a card-
board tube in a room controlled for temperature (22 ±
2 °C), relative humidity (55 ± 10 %), ventilation (20/h),
and light (12-h-light/-dark cycle, <200 Lux). Water was
available ad libitum from nipple drinkers during the
whole experiment. Bedding was exchanged every week.
Experimental diets were fed during pregnancy and lacta-
tion. The rats were fed semipurified diets meeting their
nutrient requirements according to the recommenda-
tions of the National Research Council for the AIN-93G
diet [11] (Table 1). Titanium dioxide (TiO2) was added
at 0.5 % of the diet to determine the apparent total tract
digestibility of tocopherol. The CLA supplement Lutalin®
(BASF, Ludwigshafen, Germany), which contained 29 %
each of the cis-9, trans-11 and the trans-10, cis-12 CLA
isomer (data not shown), replaced part of the soybean
oil and was supplemented in a dosage of 15 g/kg diet in
the CLA group (Table 1). In the control group, linoleic
acid rich sunflower oil (15 g/kg diet) replaced part of
the soybean oil to approximate dietary FA other than
Table 1 Ingredients and concentrations of individual tocopherols
in the experimental diets
Control diet CLA diet
Ingredient, g/kg diet
Corn starch 532 532
Casein 200 200
Sucrose 100 100
Cellulose 50 50
Soybean oil 55 55
Sunflower oil 15 -
CLA supplement (Lutalin®) - 15
Mineral mixa 35 35
Vitamin mixa 10 10
L-Cysteine 3 3
Dietary tocopherol concentration (μmol/kg diet)b
α-tocopherol 140 ± 3.28 141 ± 2.02
γ-tocopherol 60.4 ± 1.30 59.8 ± 1.43
δ-tocopherol 6.57 ± 0.37 6.58 ± 0.22
Tocopherol equivalentsc 147 ± 3.28 147 ± 2.01
aThe mineral and vitamin mix were composed as recommended for the AIN
93G diet by Reeves et al. [11]
bmeans ± standard deviations of 5 analyses of feed samples collected in weeks
1 to 5. The β- and δ-tocopherols, which are quantitatively negligible as source
of active vitamin E in soybean and sunflower oil [32], could not be separated
by HPLC and are summarized as δ-tocopherol
csum of active α, δ- and γ-tocopherol considering conversion factors of 0.10
for γ-tocopherol and 0.03 for δ-tocopherol as compared to α-tocopherol
(100 % active) [17]
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linoleic acid and CLA in both experimental diets. The
CLA supplement contained 12.8 g of total CLA/100 g
of dietary FAs which is equivalent to 0.9 g CLA/100 g
of diet. Diets were pelleted to 10 mm with a standard
pelleting device (Kahl Laborpressanlage Typ 14–175,
Reinbek, Germany). Feed was offered ad libitum and
intake was recorded weekly. After parturition, rats were
individually housed together with their pups. Litters
were adjusted to 8 pups per dam without differentiation
of gender after a maximum of 3 days after parturition.
Two dams from the control group were removed from
the experiment because 1 dam devoured the whole lit-
ter directly after parturition and 1 dam had to be killed
due to problems with delivery. All experimental proce-
dures were in strict accordance with the Appendix A of
European Convention for the Protection of Vertebrate
Animals used for Experimental and other Scientific
Purposes (ETS NO. 123). In Accordance with Article 4
par. 3 of the German Animal Welfare Law all animals
were humanely killed for scientific purposes which was
approved by the Animal Welfare Officer of the Justus-
Liebig-University, JLU No. 480_M.
Sample collection
Feed samples were taken weekly and stored at −20 °C
for later tocopherol and FA analysis. Feed intake and
weights of rats and their litter were recorded weekly.
Within 24 h after birth, 2 randomly chosen pups/litter
were decapitated and liver, lung, and the milk curd from
the stomach were removed. After 7 days, 1 pup/litter
was anesthetized with isoflurane, decapitated, and liver,
lung, subcutaneous fat and the milk curd from the stom-
ach were removed. At day 13 of lactation, the dam’s
feces, which had been excreted during the preceding
24 h, was collected and stored at −20 °C. At day 14, i.e.,
at peak lactation and before weaning [12, 13], all dams
and the remaining pups were decapitated under anaes-
thesia with carbon dioxide. From the pups, liver, lung,
subcutaneous fat and the milk curd from the stomach
were removed. Blood from the dams was collected into
heparinised polyethylene tubes (Sarstedt) and plasma was
separated by centrifugation (1100 × g, 10 min) at 4 °C and
stored at −20 °C. From the dams, liver, mammary gland
(right), gastrocnemius muscle (left) and kidney fat (left)
were excised. All tissue samples were immediately snap-
frozen in liquid nitrogen and stored at −80 °C pending
further analysis.
Determination of tissue lipid content and of fatty acid
composition
For milk curd fat determination, about 0.2 g of lyophilized
milk curd was dispersed with 3 mL of 0.9 % NaCl and the
fat was extracted with 4 mL hexane: isopropanol (HiP, 3:2,
v/v) [14] overnight. After centrifugation at 1000 × g for
5 min at 15 °C, the upper fat-containing phase was quanti-
tatively transferred to a dried and weighed test glass and
the fat extraction procedure was repeated once. The test
glass was dried to constant weight at 105 °C and
reweighed and the weighed fat was related to the initial
milk curd weight. Feed and liver FA composition was de-
termined according to Schlegel et al. [5]. In brief, 0.25 g of
milled feed or dietary oil or 50 mg of homogenized liver
tissue was extracted with 4 or 0.5 mL of HiP (3:2, v/v),
respectively, excluding light overnight on a shaker. After
centrifugation (10 min at 15 °C and 1000 × g), 250 (feed),
50 (oil) or 100 μL (liver) of the upper fat-containing phase
was evaporated to dryness under N2 at 37 °C and methyl-
ated with 50 (feed, liver) or 150 μL (oil) of trimethylsulfo-
nium hydroxide [15]. The fatty acid methyl esters were
separated by gas chromatography using a PE Clarus 580
system (Perkin Elmer, US) equipped with an automatic
split injector, a polar capillary column (50 m, 0.25 mm i.d.,
0.2 μm film thickness; Macherey and Nagel, Düren,
Germany), and a flame ionization detector. Helium was
used as carrier gas (flow rate 1.2 mL/min). The individual
fatty acid methyl esters were identified by comparing their
retention times with those of purified standards. The Δ-9
and Δ-6 desaturase indices were calculated to estimate
desaturase activities according to Masek et al. [16].
Determination of tocopherols
Concentrations of tocopherols in feed, feces, plasma, tis-
sue and milk curd were determined by high-performance
liquid chromatography (HPLC) (L-7100, LaChrom,
Merck-Hitachi, Darmstadt, Germany). Samples of 0.1 g of
feed, feces, homogenized tissue or milk curd or of 0.2 mL
of plasma, were mixed with 2 mL of a 10 g/L pyrogallol
solution (in ethanol, absolute) and 300 μL of a saturated
sodium hydroxide solution. After flushing with N2, this
mixture was heated for 30 min at 70 °C in closed glass
tubes. The tocopherols were then extracted by addition of
2 mL of n-hexane and 2 mL of bidest. water. After centri-
fugation (5 min at 10 °C and 1000 × g), an aliquot of the
hexane phase was evaporated to dryness under N2 and re-
dissolved in methanol containing 0.05 % of butylated
hydroxytoluene. The tocopherols were separated isocrati-
cally by HPLC using methanol as mobile phase, a C18 col-
umn (≥3 μm particle size, 4 mm length, 2 mm internal
diameter, Phenomenex, Germany) (pre-column) and a C-
18-reversed phase column (Luna C18 (2), 150*4.6 mm;
Phenomenex, Aschafffenburg, Germany) and detected by
fluorescence (Fluorescence Detector L-7480, LaChrom,
Merck-Hitachi). Excitation and emission wavelengths for
tocopherols were 295 and 325 nm, respectively. Tocoph-
erol equivalents were calculated using the stereoisomer of
α-tocopherol, RRR α-tocopherol, as a reference (RRR
α-tocopherol = 1), and γ-tocopherol was multiplied by
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0.10 and δ-tocopherol by 0.03 to consider the lower vita-
min activity of those 2 tocopherol isomers [17].
Determination of tocopherol digestibility
The apparent total tract digestibility of tocopherol was
determined using TiO2 as an indigestible marker. The
TiO2 concentrations in feed and feces were measured
photometrically according to Brandt and Allam [18] and
the digestibility was calculated as: apparent total tract di-
gestibility = 100 – {(% TiO2 in diet/% TiO2 in feces) × (%
tocopherol in feces/% tocopherol in diet) × 100}.
RNA isolation and Quantitative real-time RT-PCR
Total RNA was isolated from 20 mg of liver tissue (dams,
pups) using Trizol reagent (Invitrogen) according to the
manufacturer’s protocol and from 80 mg of kidney fat
(dams) or subcutaneous fat (pups), or from 40 mg of mam-
mary gland tissue (dams) using the RNeasy Lipid Tissue
Mini Kit (Qiagen, Hilden, Germany). The RNA concentra-
tion and purity were estimated from the optical density at
260 and 280 nm, respectively, using an Infinite 200 M mi-
croplate reader and a NanoQuant Plate (both from Tecan,
Männedorf, Switzerland) and RNA was stored at −80 °C.
The cDNA was synthesized from 1.2 μg of total RNA
using 100 pmol dT18 primer (Eurofins MWG Operon,
Ebersberg, Germany), 1.25 μL 10 mmol/L dNTP mix
(GeneCraft, Lüdinghausen, Germany), 5 μL buffer
(Fermentas, St. Leon-Rot, Deutschland), and 60 units M-
MuLV Reverse Transcriptase (MBI Fermentas, St. Leon-
Rot, Germany) at 42 °C for 60 min, and a final inactivating
step at 70 °C for 10 min in Biometra ThermalCycler
(Whatman BiometraW, Göttingen, Germany). The cDNA
was diluted 1:2 with DNase/RNase free water and stored
at −20 °C. The qPCR was carried out on a Rotorgene 2000
system (Corbett Research, Mortlake, Australia) using 2 μL
cDNA combined with 9 μL of a mixture composed of
5 μL KAPA SYBR FAST qPCR Universal Mastermix
(Peqlab, Erlangen, Germany), 0.2 μL each of 10 μM for-
ward and reverse primers and 3.6 μL DNase/RNase free
water in 0.1 mL tubes (Ltf Labortechnik, Wasserburg,
Germany). Gene-specific primer pairs were from [19] or
were designed using PRIMER3 and BLAST and obtained
from Eurofins MWG Operon (Ebersberg, Germany)
(Table 2). The amplification of a single product of the
expected size was approved using 2 % agarose gel electro-
phoresis stained with GelRed™ nucleic acid gel stain (Bio-
tium Inc., Hayward, CA). The Ct values of target and
reference genes were obtained using Rotorgene Software
5.0 (Corbett Research). All Ct values were transformed into
relative quantification data using the 2-ΔCt equation [20]
but the efficiencies of the reference and target genes were
determined and used for the calculations instead of using
an efficiency of 2. The highest relative quantities for each
gene were set to 1. These expression values of target genes
were normalized using the GeNorm normalization factor
[21]. Using the Microsoft Excel-based application GeNorm,
the GeNorm normalization factor was calculated as the
geometric mean of expression data (relative quantities) of
the three most stable out of four to six tested potential ref-
erence genes (ATP5B, CANX, MDH1, RPL13, TOP1, YW
HAZ for liver and fat; ACTB instead of ATP5B for mam-
mary gland). The normalized expression values data set
was corrected for outliers. Means and SD were calculated
from normalized expression data for samples of the same
Table 2 Characteristics of primers used for qPCR
Gene GeneBank
accession no.
Sense primer (5′-3′) Antisense primer (5′-3′) Product size, bp Primer efficiency Annealing Temp., °C
Reference genes
ACTB NM_031144.2 GACCTCTATGCCAACACAGT CACCAATCCACACAGAGTAC 154 1.92 60
ATP5B NM_134364.1 GCACCGTCAGAACTATTGCT GAATTCAGGAGCCTCAGCAT 203 1.90 60
CANX NM_172008.2 CCAGATGCAGATCTGAAGAC CTGGGTCCTCAATTTCACGT 175 2.31 60
MDH1 NM_033235.1 CAGACAAAGAAGAGGTTGCC CGTCAGGCAGTTTGTATTGG 206 1.97 60
RPL13 NM_031101.1 CTTAAATTGGCCACGCAGCT CTTCTCAACGTCTTGCTCTG 198 1.94 60
TOP1 NM_022615.1 GAAGAACGCTATCCAGAAGG GCTTTGGGACTCAGCTTCAT 137 2.00 60
YWHAZ NM_013011.3 GACGGAAGGTGCTGAGAAA GCAGCAACCTCAGCCAAGT 198 2.09 60
Target genes
TTPA NM_013048.2 GGAGGTGGAAACTCAACGGAA AGCAGCAATCTTCTTGGCTACA 109 1.93 60
CYP3A1 NM_013105.2 TGGTAATAGACTTGAGAGAG GGGCAGATATACATAAGGA 196 1.90 56
LDLR NM_175762.2 ACAGTGTCCTCCCAAGTCCAA GCAAATGTGGATCTCGTCCTC 222 1.87 60
SCARB1 NM_031541.1 GGTGCCCATCATTTACCAAC CCCTACAGCTTGGCTTCTTG 162 1.94 60
LPL NM_012598.2 GAGATTTCTCTGTATGGCACA CTGCAGATGAGAAACTTTCTC 276 1.99 60
Primers were designed using Primer3 from gene sequences obtained from GeneBank and tested in silico using BeaconDesigner and mfold. Primer specificity was
determined using a BLAST search
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experimental group. The mean of the control group was set
to 1 and the means and SD of the CLA group was scaled
proportionally.
Statistics
Data were analysed by one-way analysis of variance
using the software R version 3.1.3 (https://cran.r-projec-
t.org). For analysis of data with measurements at only
one time point, treatment was considered as fixed and
animal as random effect and the function lme, package
nlme, was used. Time-series data were monitored over
time; the model included treatment, time and their
interaction as fixed effects and animal as random effect
using lmer; pairwise comparisons were done using the
Hochberg test and the function lsmeans.
Results
Tocopherol and fatty acid composition of the diet
The concentration of tocopherols were similar in both
diets (Table 1). The FA composition of the experimental
diets is shown in Table 3. As intended, the FA compos-
ition of the 2 experimental diets was similar and differed
only in their contents of CLA and linoleic acid (Table 3).
Effects of CLA on performance, liver lipids, tocopherol
digestibility, and tissue tocopherol concentration of dams
Feed intake was similar in control and CLA-fed rats, but
increased after delivery with the onset of lactation in
both groups (Table 4). Consequently, the dietary intake of
tocopherols increased with the onset of lactation in week
4 but was similar between groups (Table 4). Body weight
development of dams before and after delivery was not in-
fluenced by the supplementation of CLA to the diet
(Table 4). After 5 experimental weeks, at peak lactation,
dam liver weights (% of body weight) were similar in both
groups, however, liver TG concentrations were lower in
CLA-fed dams compared to control dams (Table 5). The
FA composition of total liver lipids differed between
groups (Table 5). As expected, the concentrations of both
CLA isomers and of stearic acid were higher in the CLA
group as compared to the control group while the concen-
trations of mono- and polyunsaturated C18 FAs including
linoleic acid were lower (Table 5). In addition, Δ-9 and Δ-
6 desaturase indices, i.e., the estimated desaturase activ-
ities, were lower in the CLA-fed groups compared to the
control group (Table 5). The apparent digestibility of toc-
opherol was considerably lower in the CLA-fed dams than
in the Control dams (Table 6). Still, concentrations of
tocopherols in plasma and muscle of dams were not influ-
enced by CLA feeding (Table 6). However, the tocopherol
concentration in the liver decreased by 24 % in the CLA-
fed dams whereas that in the adipose tissue increased by
47 % (Table 6). Both fat and tocopherol concentrations in
the milk curd were similar in both groups (Table 7). Toc-
opherol concentrations in milk curd were highest one day
after delivery and decreased during the first 2 weeks of
lactation (Table 7).
Effects of CLA on performance and tissue tocopherol
concentration of pups
At delivery, litter weights were similar in the control
(67.8 ± 14.0 g) and the CLA group (69.0 ± 16.3 g) (P =
0.85). Litter size did not differ between the control
(11.2 ± 2.33 pups per litter) and CLA group (11.0 ±
3.06) as well (P = 0.88). All 26 rats used for data analysis
delivered within 3 days and litter size was standardized to
8 pups per dam on average 1.1 days after birth (maximum
2 days after birth). Litter development after litter size
standardization was similar in both groups (Table 7). Liver
weights were similar between groups both in the newborn
pups and in 14 day-old pups (Table 7). Likewise, weights
of the lung were similar in pups nursed by CLA-fed dams
(2.28 ± 0.42 g/100 g BW) and in pups nursed by Control
dams (2.45 ± 0.62 g/100 g BW) (P = 0.42). The tocopherol
concentration in livers and lungs of pups did not differ be-
tween the two groups, but were higher in new-born pups
as compared to 7 and 14 day-old pups (Table 7). In the
adipose tissue, concentrations of tocopherols were higher
in the CLA group as compared to the control group in
the 14 day-old pups, but did not differ in the 7-day old
pups (Table 7).
Effects of CLA on expression of genes involved in
metabolism of lipids and tocopherols in liver, adipose
tissue and mammary gland of dams and pups
In the liver of dams at day 14 of lactation, the gene ex-
pression of TTPA was similar in both groups, and the
CLA supplement did also not influence the expression
of CYP3A1, a cytochrome P450 enzyme which is im-
portant for tocopherol degradation in rat liver [22, 23]
Table 3 FA composition of the control and CLA-supplemented
diet (g/100 g of total FAs)a
Control diet CLA diet
C 16:0 10.04 ± 0.02 10.04 ± 0.06
C 18:0 3.22 ± 0.04 3.38 ± 0.07
C 18:1 n9 22.51 ± 0.21 22.91 ± 0.09
C 18:1 n7 1.37 ± 0.01 1.38 ± 0.01
C 18:2 n6 57.51 ± 0.17 45.04 ± 0.32
C 18:3 n3 4.43 ± 0.11 4.46 ± 0.09
C18:2 cis-9, trans-11 CLA <0.1 6.04 ± 0.21
C18:2 trans-10, cis-12 CLA <0.1 5.82 ± 0.21
C 20:0 0.25 ± 0.01 0.27 ± 0.01
C 20:1 0.19 ± 0.01 0.21 ± 0.01
C 20:5 n3 0.42 ± 0.02 0.41 ± 0.02
amean ± standard deviation of 5 analyses for diets (samples of week 1–5)
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(Fig. 1a). In the adipose tissue, the gene expression of
LDLR and SCARB1, which are involved in uptake of li-
poproteins and lipid-soluble vitamins, were enhanced by
50 and 30 %, respectively, in the CLA group as com-
pared to the control group, but the expression of LPL
was similar (Fig. 1b). In liver and mammary gland, the
gene expression of LDLR, SCARB1 and LPL was similar
between groups (Fig. 1a and 1c). Similarly, in the pup’s
liver, gene expression of TTPA, CYP3A1, LDLR, SCA
RB1 and LPL were not influenced by CLA feeding
(Fig. 2a). However, in the adipose tissue, gene expres-
sion of LDLR and SCARB1 were enhanced in the pups
nursed by CLA-fed dams compared to those nursed by
control dams (Fig. 2b).
Discussion
In our study, feed intake and growth of the pregnant
and lactating rats was not influenced by dietary supple-
mentation of 0.9 g of total CLA/100 g of diet. This has
been observed by others as well when CLAs were sup-
plemented to rat diets in dosages between 0.25 and
1.35 g CLA/100 g of diet [2, 24, 25]. Like in the present
study, pup growth has been found unchanged when rat
diets were supplemented with 0.25 to 0.5 g CLA/100 g
of diet [2, 24]. On the other hand, when higher dietary
CLA concentrations of 1.35 to 1.47 g CLA/100 g of the
dams’ diet have been used, pup growth as well as the
dams’ milk fat contents was reduced [1, 25]. The obser-
vation of our study that the fat contents of the milk curd
Table 4 Feed and tocopherol intake and body weight of dams fed either a control or a CLA-supplemented dietd
Week SEM P value
1 2 3 4 5 Treatment Time tr.*time
Feed intake, g/d
Control 21.7a 20.8a 21.9a 25.2b 43.2c 0.57 0.43 <0.001 0.25
CLA 21.1a 20.4a 20.8a 26.5b 43.8c
Tocopherol intake, μmol/de
Control 3.18a 3.05a 3.21a 3.69b 6.33c 0.08 0.99 <0.001 0.40
CLA 3.09a 2.99a 3.05a 3.88b 6.41c
Body weight, g
Control 258a 292b 286b 294b 289b 4.9 0.95 <0.001 0.75
CLA 256a 293b 283b 289b 285b
a-cMeans with superscripts without a common letter differ at P < 0.05. dValues are means, n = 12–14. Means with superscripts without a common letter differ at
P < 0.05. Weeks 1–3: pregnancy, weeks 4–5: lactation; weight for week 3 is after delivery; tr., treatment. Data were analysed by two-way ANOVA with treatment,
time and their interaction as fixed effects and animal as random effect
esum of active α, δ- and γ-tocopherol considering conversion factors of 0.10 for γ-tocopherol and 0.03 for δ-tocopherol as compared to α-tocopherol (100 % active) [17]
Table 5 Liver weights, liver TG content and FA composition
of total liver lipids of dams fed either a control or a CLA-
supplemented diet (g/100 g of total FA)a
Control CLA SEM P value
Liver, g/100 g BW 5.05 5.12 0.16 0.70
Liver TG, μmol/g liver 111 84 12 0.028
C 14:0 1.17 1.24 0.086 0.45
C 16:0 29.7 30.1 0.84 0.69
C 16:1 n9 4.80 3.85 0.40 0.026
C 18:0 9.25 12.7 0.77 <0.001
C 18:1 n9 31.5 28.7 1.05 0.012
C 18:2 n6 15.1 12.7 0.87 0.010
C 18:3 n6 1.22 0.81 0.073 <0.001
C 18:3 n3 0.32 0.29 0.027 0.33
C18:2 cis-9, trans-11 CLA <0.1 0.76 0.061 <0.001
C18:2 trans-10, cis-12 CLA <0.1 0.33 0.033 <0.001
C 20:4 n6 5.67 7.10 0.61 0.028
C 22:6 1.16 1.52 0.18 0.053
Δ-9D 16 (16:1n9/16:0)b 0.16 0.13 0.011 0.0043
Δ-9D 18 (18:1n9/18:0)b 3.47 2.39 0.256 <0.001
Δ-6D n6 (18:3n6/18:2n6)b 0.08 0.07 0.004 <0.001
aValues are means at day 14 of lactation, n = 12–14. Data were analysed by
one-way ANOVA with treatment as fixed effect and animal as random effect
bto estimate desaturase activities, desaturase indices were calculated as
product-to precursor ratios of individual fatty acids. Δ-9D 16, Δ-9 desaturase
index for C16:1n9, Δ-9D 18, Δ-9 desaturase index for C18:1n9, Δ-6D n6, Δ-6
desaturase index for the n6 line
Table 6 Apparent tocopherol digestibility and tocopherol
concentration in plasma and tissues of dams fed either a
control or a CLA-supplemented dieta
Control CLA SEM P value
Tocopherol digestibility, % 77.9 68.7 2.09 <0.001
Plasma and tissue tocopherol concentrations
Plasma, μmol/l 22.1 24.5 1.44 0.12
Liver, nmol/g 491 374 27.5 <0.001
Adipose tissue, nmol/g 136 199 14.2 <0.001
Muscle, nmol/g 45.0 45.3 3.29 0.91
aValues are means at day 14 of lactation, n = 12–14. Data were analysed by
one-way ANOVA with treatment as fixed effect and animal as random effect
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did not differ between groups fits well to the finding that
pup growth was not influenced by CLA feeding of the
dams and may be related to the use of lower CLA dos-
ages as compared to the studies of Ringseis et al. [1] and
Hayashi et al. [25]. As expected, the CLA concentrations
in liver lipids were higher in the CLA group as com-
pared to the control group, which confirms that CLA
was incorporated into body lipids. Also, the concentra-
tions of oleic and linoleic acid and of gamma-linoleic
acid in liver lipids and the Δ-9 and Δ-6 desaturase indi-
ces decreased which can be explained by the t10,c12-
CLA-induced inhibition of the stearoyl-CoA desaturase
(SCD; Δ-9 desaturase) and the fatty acid desaturase 2
(FADS2; Δ-6 desaturase), respectively [26, 27].
In the dams, our hypothesis that CLA affect body con-
centrations of tocopherols was confirmed, because the con-
centrations of tocopherols were decreased in liver and
increased in the adipose tissue. This partly confirms find-
ings of Chao et al. [9] and Chen et al. [10] who reported
increased concentrations of tocopherols in, amongst others,
adipose tissue of growing mice. In general, increased
tocopherol concentrations in the adipose tissue could be
explained either by an accumulation of tocopherols due to
reductions in fat mass or by enhanced deposition of
Table 7 Litter development, milk curd fat content and tocopherol concentration in milk curd and tissues of pups nursed by dams
fed either a control or a CLA-supplemented dietd
Day after birth 1 7 14 P value
Treatment group Control CLA Control CLA Control CLA SEM Treatment Time tr.*time
Performance of pups
Litter weight, g 56.4a 57.7a 143b 149b 264c 272c 3.35 0.36 <0.001 0.48
Pup weight, g 7.1a 7.2a 17.9b 18.6b 38.2c 39.2c 0.46 0.39 <0.001 0.60
Liver weights and liver triglyceride concentrations
Liver, g/100 g BW 4.62a 4.80a NA NA 3.10b 3.32b 0.13 0.30 <0.001 0.92
Liver TG, μmol/g liver 32.6 48.5 NA NA 40.9 36.7 3.28 0.21 0.69 0.032
Fat content
Milk curd, μmol/g 299 312 327 292 329 301 6.40 0.059 0.51 0.015
Tocopherol concentration
Milk curd, nmol/g 500a 429a 57.5b 55.6b 65.5b 59.8b 11.4 0.084 <0.001 0.077
Liver, nmol/g 381a 320a 121b 102b 102b 91b 19.2 0.21 <0.001 0.67
Lung, nmol/g 35.8a 39.3a 72.1b 67.9b 65.6b 71.0b 2.39 0.62 <0.001 0.24
Adipose tissue, nmol/g NA NA 52.2a 50.9a 49.0a 71.9b 2.46 0.001 0.002 <0.001
a-cMeans with superscripts without a common letter differ at P < 0.05. dValues are means after standardization to 8 pups per litter, n = 12–14. Means with
superscripts without a common letter differ at P < 0.05. tr., treatment. NA, not analysed. Data were analysed by two-way ANOVA with treatment, time and their
interaction as fixed effects and animal as random effect
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Fig. 1 Relative mRNA abundance of genes involved in lipid and tocopherol metabolism in liver (a), adipose tissue (b) and mammary gland (c) of rats
fed either a control or a CLA-supplemented diet. Bars represent mean ± SEM of 12 to 14 rats per group and are expressed as fold of relative mRNA
abundance of the control group. *, different from the control group at P < 0.05. CYP3A1, cytochrome P450, family 3, subfamily A, polypeptide 1; LDLR,
low density lipoprotein receptor; LPL, lipoprotein lipase; SCARB1, scavenger receptor class B, member 1; TTPA: α-tocopherol transfer protein
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tocopherols in the adipose tissue or by both processes. We
didn’t measure adipose tissue mass in the present study
and thus cannot exclude a reduction of adipose tissue mass
due to CLA feeding as shown by Salgado et al. [28]. How-
ever, our data do suggest a reallocation of tocopherols from
the liver, where tocopherol concentrations decreased, to the
adipose tissue where tocopherol concentrations increased.
The finding that liver tocopherol concentrations decreased
are in contrast to other studies, which found increased
liver tocopherol concentrations after CLA supplementa-
tion [9, 10]. Likewise, our data contrast with that of Chen
et al. [10] where tocopherol digestibility was not influ-
enced by CLA-feeding in mice, whereas we observed that
tocopherol digestibility in CLA-fed dams was reduced
compared to control dams. A reduced tocopherol absorp-
tion may help to explain reduced liver tocopherol concen-
trations due to CLA-feeding in the present study. Also, in
contrast to others who have shown that gene expression
of the TTPA in the liver of growing mice fed similar
dosages of CLA (0.74–0.80 %) in the diet was enhanced
[9, 10], the TTPA mRNA concentrations in the liver of the
lactating dams in our study were not altered. The TTPA
triggers association of α-tocopherol with lipoproteins and
the secretion from the liver into the bloodstream [7]. It
seems also likely that CLA supplementation did not influ-
ence tocopherol degradation in the present study, because
gene expression of CYP3A1 was similar in both groups
and the CYP-dependent ω-hydroxylation of tocopherols is
the rate-limiting step in tocopherol degradation [23]. Liver
and plasma concentrations of α-carboxyethyl hydroxy-
chroman, the degradation product of tocopherol, excreted
via urine and bile, have been unchanged by feeding dietary
CLA in the study of Chen et al. [10] as well. However, our
data indicate that plasma lipoproteins and thus also to-
copherols were preferably taken up by the adipose tissue
as the gene expression of LDLR and SCARB1, which are
involved in uptake of lipids and tocopherols from lipopro-
teins [7], where enhanced in the adipose tissue, but not
increased in liver and mammary gland. In all tissues inves-
tigated, gene expression of the LPL, which is involved in
TG uptake from VLDL and chylomicrons [29], was not in-
fluenced by CLA. This was unexpected because in the
mammary gland of both rat [1] and ruminants [4, 5], the
LPL has been shown to be down-regulated upon CLA-
feeding. Interestingly, the uptake of α-tocopherol is
dependent upon LPL in the mammary gland of lactating
rats, but not in adipose tissue [30]. This fits to our obser-
vation that tocopherol concentrations were enhanced in
the adipose tissue although LPL gene expression was not.
The latter is also in line with a study of Andreoli et al.
[31], which has shown that the activity of the LPL in white
adipose tissue was not influenced when 1.0 or 2.9 % of
CLA were included into a rat diet.
The pups’ tocopherol intake was probably similar be-
cause the tocopherol concentration in the milk curd was
similar in both groups. Also, our sampling was done at
peak lactation, 14 days after birth, or before which is be-
fore onset of solid feed intake by pups occurs (~18 days
after birth) [13], which was also confirmed by visual
examination of the pups’ stomach contents in our study.
Accordingly, the effects of CLA-feeding of the dams on the
pups’ body tocopherol status was minor and limited to the
adipose tissue at the last sampling time point. Only at this
time point, at 14 days of age, pups nursing CLA-fed dams
had higher adipose tissue tocopherol concentrations than
those from the control group, and the increased gene ex-
pression of LDLR and SCARB1 indicate that tocopherol
uptake into the pup’s adipose tissue was increased in pups
nursed by CLA-fed dams compared to control dams. Still,
we cannot exclude the possibility that the higher tocopherol
concentration in the pups’ adipose tissue was partly due to
a simple concentration effect: the CLA which can be trans-
ferred to the pups’ body via milk [1] may influence the
pups’ lipid metabolism as well and reduce adipose tissue
mass, which may in turn lead to enhanced tocopherol con-
centrations in the remaining adipose tissue mass. Together,
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Fig. 2 Relative mRNA abundance of genes involved in lipid and tocopherol metabolism in liver (a) and adipose tissue (b) of pups nursed by dams fed
either a control or a CLA-supplemented diet. Bars represent mean ± SEM of 12 pups per group and are expressed as fold of relative mRNA abundance
of the control group. *, different from the control group at P < 0.05. CYP3A1, cytochrome P450, family 3, subfamily A, polypeptide 1; LDLR, low density
lipoprotein receptor; LPL, lipoprotein lipase; SCARB1, scavenger receptor class B, member 1; TTPA: α-tocopherol transfer protein
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this indicates that dietary CLA supplementation of preg-
nant and lactating rats in dosages similar to those in the
present study do not influence milk tocopherol concentra-
tions and hardly influence tocopherol status in pups.
Conclusions
In conclusion, we demonstrate that dietary CLA influ-
ence tissue tocopherol status in lactating rats. We also
present evidence that dietary CLA influence tocopherol
metabolism on gene expression level. Based on our data,
we conclude that CLA increases liver export of α-
tocopherol and uptake of tocopherols from lipoproteins
into the adipose tissue but not into mammary gland. We
also show that CLA has only minimal effects on tissue
tocopherol status of pups nursed by CLA-fed dams al-
though it seems that the CLA transferred to pups via
milk affect the pup’s tocopherol metabolism similar than
it does in dams. These data indicate that supplementa-
tion of CLA in pregnant and lactating animals is uncrit-
ical in terms of tocopherol status of new-borns.
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